Thomas R Cate

Summary

Affiliation: Baylor College of Medicine
Country: USA

Publications

  1. pmc A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects
    Thomas R Cate
    Baylor College of Medicine, One Baylor Plaza, MS BCM 280, Houston, TX 77030, United States
    Vaccine 28:2076-9. 2010
  2. pmc Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans
    Robert B Couch
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, MS BCM 280, Houston, TX, USA
    Vaccine 27:5344-8. 2009
  3. pmc Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccine
    Robert L Atmar
    Department of Medicine, Baylor College of Medicine, Houston, TX, USA
    Vaccine 29:8066-72. 2011
  4. pmc A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults
    Robert L Atmar
    Department of Medicine, Baylor College of Medicine, Houston, TX 77030, United States
    Vaccine 25:5367-73. 2007
  5. doi request reprint Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variants
    Wendy A Keitel
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030, USA
    J Infect Dis 198:1016-8. 2008
  6. pmc Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects
    Robert B Couch
    Baylor College of Medicine, One Baylor Plaza, MS BCM280, Houston, TX 77030, United States
    Vaccine 25:7656-63. 2007
  7. pmc A phase I evaluation of inactivated influenza A/H5N1 vaccine administered by the intradermal or the intramuscular route
    Shital M Patel
    Baylor College of Medicine, Medicine Infectious Diseases, BCM MS 280, One Baylor Plaza, Houston, TX 77030, United States
    Vaccine 28:3025-9. 2010
  8. ncbi request reprint Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations
    Robert L Atmar
    Department of Medicine, Baylor College of Medicine, Houston, TX, USA
    Clin Infect Dis 43:1135-42. 2006
  9. ncbi request reprint Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons
    Wendy A Keitel
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Tex 77030, USA
    Arch Intern Med 166:1121-7. 2006

Detail Information

Publications9

  1. pmc A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects
    Thomas R Cate
    Baylor College of Medicine, One Baylor Plaza, MS BCM 280, Houston, TX 77030, United States
    Vaccine 28:2076-9. 2010
    ..Ensuring an increased antibody response to the NA antigen in inactivated influenza virus vaccines should increase the protection against influenza. An increased quantity of the NA antigen in the vaccine will ensure an increased response...
  2. pmc Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans
    Robert B Couch
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, MS BCM 280, Houston, TX, USA
    Vaccine 27:5344-8. 2009
    ..Thus, despite exhibiting a significant adjuvant effect in mice, interferon did not exhibit an adjuvant effect for induction of antibody in respiratory secretions of humans to inactivated influenza virus vaccine given intranasally...
  3. pmc Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccine
    Robert L Atmar
    Department of Medicine, Baylor College of Medicine, Houston, TX, USA
    Vaccine 29:8066-72. 2011
    ..Persons born before 1968 were not more likely to respond to a G9 H9N2 influenza vaccine than persons born in 1970 or later...
  4. pmc A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults
    Robert L Atmar
    Department of Medicine, Baylor College of Medicine, Houston, TX 77030, United States
    Vaccine 25:5367-73. 2007
    ..Nasal IgA antibody responses were more common when vaccine was administered IN; and, when the IN dosage was increased, the primary benefit from IN vaccine over IM vaccine appeared to be greater induction of nasal secretory antibody...
  5. doi request reprint Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variants
    Wendy A Keitel
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030, USA
    J Infect Dis 198:1016-8. 2008
    ..Increasing the influenza vaccine dosage safely and predictably enhanced antibody responses to the vaccine virus and to subsequent, antigenically different, influenza A/H1N1 variants...
  6. pmc Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects
    Robert B Couch
    Baylor College of Medicine, One Baylor Plaza, MS BCM280, Houston, TX 77030, United States
    Vaccine 25:7656-63. 2007
    ..These increased immune responses should provide increased protection against influenza in the elderly...
  7. pmc A phase I evaluation of inactivated influenza A/H5N1 vaccine administered by the intradermal or the intramuscular route
    Shital M Patel
    Baylor College of Medicine, Medicine Infectious Diseases, BCM MS 280, One Baylor Plaza, Houston, TX 77030, United States
    Vaccine 28:3025-9. 2010
    ..Higher dosages of H5 HA and/or inclusion of adjuvant will be required to enhance immunogenicity by the ID route...
  8. ncbi request reprint Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations
    Robert L Atmar
    Department of Medicine, Baylor College of Medicine, Houston, TX, USA
    Clin Infect Dis 43:1135-42. 2006
    ..Influenza A/H9N2 viruses can infect humans and are considered to be a pandemic threat. Effective vaccines are needed for these and other avian influenza viruses...
  9. ncbi request reprint Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons
    Wendy A Keitel
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Tex 77030, USA
    Arch Intern Med 166:1121-7. 2006
    ..Immune responses after influenza immunization are reduced in elderly individuals, the group at greatest risk for complications and death after influenza. Improved vaccines are needed to address this problem...